Tesla has announced that longtime Chipotle executive Jack Hartung will join the EV giant's board. Hartung served as CFO of the fast-food chain for 22 years before becoming president last year.

A minor earnings miss triggered a negative momentum for the stock, which was amplified by the sudden resignation of Andre Witty as a CEO and completely slashing FY2025 guidance. Cost pressures from Medicare and Optum and an alleged DOJ probe on Medicare weigh on the outlook and justify caution. Multiple valuation models using conservative assumptions and technicals suggest the stock is undervalued.

For warehouse robotics company Symbotic NASDAQ: SYM, breaking records on important business metrics was key to its latest big post-earnings move. Symbotic shares saw a significant 6% rise after the industrial company's latest earnings report came out on May 7.

CAVA's fiscal first-quarter top line benefits from strong same-restaurant sales growth and new restaurant openings.

GitLab offers a compelling high-risk, high-reward opportunity for investors seeking to move up the Efficient Frontier in their portfolios. The company stands out for its deep AI integration, strong customer traction, and growing adoption of its premium subscription tier. Though management gave conservative guidance for FY '26, anecdotal evidence suggests the company is performing very well.

Gold price forecast: XAU/USD teeters on 50-day MA. A sustained breakdown with volume could confirm real liquidation, not just profit-taking.

PKX plans to invest KRW 525.6 billion in POSCO Future M's capital increase, acquiring the full allocation of new shares corresponding to its 59.7% ownership.

Cava co-founder and CEO Brett Schulman joins 'Squawk Box' to discuss the company's quarterly earnings results, state of the consumer, impact of tariffs, growth outlook, and more.

Prologis is a dominant logistics REIT with a fortress balance sheet, diversified tenant base, and a stellar track record of dividend growth. Despite recent headwinds from oversupply and higher rates, industrial construction starts are dropping, setting up a favorable supply-demand shift for Prologis. Growth catalysts include energy-efficient property upgrades, EV infrastructure, solar, and high-yield data center expansion, leveraging its global scale.

Lars Fruergaard Jorgensen, the chief executive of once-highflying Danish drugmaker Novo Nordisk, is stepping down after eight years in the role, the maker of Ozempic and Wegovy drugs announced on Friday.

EW stock is on investors' radars due to the promising structural heart opportunities and impressive TMTT portfolio.

I give a hold rating for The Cheesecake Factory as the stock is already trading above its historical valuation range. Despite strong 1Q25 performance, including 4% revenue growth and margin expansion, the near-term upside appears limited without significant growth or earnings revisions. CAKE's growth is driven by new store openings and the successful Cheesecake Rewards program, but the market has likely priced in these positives.

This week's rally is particularly encouraging for investors who like to invest in small-cap stocks. The Russell 2000 index, widely considered to be the small-cap index, is up about 3.8% for the week.

EXC makes a strong case for investment, given its growth prospects, return on equity, solvency and capability to increase shareholder value.

NEW YORK, NY / ACCESS Newswire / May 16, 2025 / Levi & Korsinsky notifies investors that it has commenced an investigation of Informatica Inc. ("Informatica Inc.") (NYSE:INFA) concerning possible violations of federal securities laws. On February 13, 2025, Informatica issued a press release announcing its fourth quarter 2024 financial results, missing revenue forecasts and issuing disappointing fiscal 2025 guidance on the back of disappointing renewal rates.

NEW YORK, NY / ACCESS Newswire / May 16, 2025 / Levi & Korsinsky notifies investors that it has commenced an investigation of Lantheus Holdings, Inc. ("Lantheus Holdings, Inc.") (NASDAQ:LNTH) concerning possible violations of federal securities laws. On May 7, 2025, Lantheus reported its financial results for the first quarter of 2025.

NEW YORK, NY / ACCESS Newswire / May 16, 2025 / Levi & Korsinsky notifies investors that it has commenced an investigation of Vestis Corporation ("Vestis Corporation") (NYSE:VSTS) concerning possible violations of federal securities laws. On May 6, 2025, Vestis reported a significant drop in 2Q 2025 revenue results that missed analysts' expectations.

NEW YORK, NY / ACCESS Newswire / May 16, 2025 / Levi & Korsinsky notifies investors that it has commenced an investigation of nCino, Inc. ("nCino, Inc.") (NASDAQ:NCNO) concerning possible violations of federal securities laws. On April 1, 2025, nCino reported positive 4Q 2025 financial results but announced fiscal 2026 guidance that was below analysts' expectations.

NEW YORK, NY / ACCESS Newswire / May 16, 2025 / Levi & Korsinsky notifies investors that it has commenced an investigation of Globus Medical, Inc. ("Globus Medical, Inc.") (NYSE:GMED) concerning possible violations of federal securities laws. Globus issued a press release reporting its financial results for the first quarter of 2025 On May 8, 2025.

Acquisition is Strong Strategic Fit for BioMarin, Adding INZ-701, a Phase 3 Enzyme Replacement Therapy Being Developed for Treatment of ENPP1 Deficiency First Pivotal Data Readout in Children Expected in Early 2026 with Potential Launch in 2027; Additional Clinical Programs to Expand to Patients of all Ages Potential First-in-Disease Treatment for ENPP1 Deficiency Conference Call and Webcast Scheduled Today at 8:45 a.m. ET SAN RAFAEL, Calif.